A Multicenter Study of Artificial Intelligence Model for Fetal Congenital Heart Disease
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorBeijing Anzhen Hospital
About this trial
This study addresses congenital heart disease in fetuses, a specific birth defect, by collaborating with multicenter medical institutions across China. It prospectively collects echocardiographic screening, diagnostic images, and structured parameter data from both normal and abnormal fetuses. Cases are followed up, and artificial intelligence (AI) models are developed to extract fetal heart echocardiographic image features and analyze the data. This process allows for the analysis of the AI models' accuracy, sensitivity, and specificity, and verifies the application value of AI models in fetal heart echocardiographic screening and diagnosis.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Single or multiple pregnancy;
Gestational age 16-40 weeks;
Fetal echocardiographic images are clear and complete;
Clinical data are complete and detailed;
Disqualifiers
Fetal echocardiographic images are incomplete or of poor quality that cannot be used for research;
Refusal or loss of follow-up
Trial population
The study population was from 20 multi-center medical institutions in China, and pregnant women who underwent fetal echocardiography between 16 and 40 weeks of gestation.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Diagnostic efficiency of AI model for fetal CHD
Time frame
From enrollment to diagnostic verification, the evaluation period should not exceed 12 month.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: